Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research

The study objective is to collect biospecimen samples (e.g., whole blood) from participants diagnosed with active lung cancer to investigate the immune response to develop treatments and therapies.

Inclusion Criteria:Participants willing and able to provide written informed consentParticipants are willing and able to provide appropriate photo identificationParticipant's age 18 - 100 years oldParticipants diagnosed with active non-small cell lung cancer (Adenocarcinoma or Squamous Cell only. All stages are acceptable.)Participants must have associated tissue biomarker data (EFGR and MET mutations) in their medical recordsExclusion Criteria:Participants who are pregnant or nursingParticipants with a known history of HIV, hepatitis, or other infectious diseasesParticipants who have taken an investigational product in the last 30 daysParticipants who have experienced excess blood loss, including blood donation defined as 250 mL in the last month or 500 mL in the previous two monthsParticipants currently enrolled in a clinical trialParticipants currently in remission